Literature DB >> 8246172

Autoradiographic distribution of [14C]tetrahydrobiopterin and its developmental change in mice.

M Hoshiga1, K Hatakeyama, M Watanabe, M Shimada, H Kagamiyama.   

Abstract

Tetrahydrobiopterin (BH4) is a regulatory factor of phenylalanine degradation as well as of catecholamine, serotonin and nitric oxide synthesis. To understand the in vivo metabolism of BH4, whole-body autoradiography was performed on mice at various developmental stages after injection of a low dose (45 micrograms/kg) of radiolabeled BH4. In adult mice, high levels of radioactivity were accumulated in the liver and kidney, suggesting that BH4 in these organs is supplied not only by intracellular de novo biosynthesis but also by uptake from the blood. In contrast, little radioactivity was found in the brain, adrenal medulla and bone marrow, in which high levels of endogenous BH4 are found, suggesting that BH4 in these organs is supplied mainly by intracellular biosynthesis. Biopterin, a fully oxidized form of BH4, was not accumulated in any tissues and was excreted rapidly. In pregnant mice, maternal BH4 passed through the placenta and was distributed uniformly to the fetal tissues. Neonatal (5- and 7-day-old) mice had a similar distribution pattern of labeled BH4 to that of adult mice, except for the liver and kidney: in the liver, selective accumulation of BH4 in the adult was not observed in 5-day-old mice; in the kidney, the distribution of high radioactivity to the inner cortex observed in the adult was found in neither 5- nor 7-day-old mice. The developmental increase in hepatic BH4 accumulation was correlated with those of the activities of phenylalanine hydroxylase and GTP cyclohydrolase I, the rate-limiting enzyme of the BH4 biosynthetic pathway.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8246172

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

1.  Tetrahydrobiopterin activates brown adipose tissue and regulates systemic energy metabolism.

Authors:  Yasuo Oguri; Yoshihito Fujita; Abulizi Abudukadier; Akiko Ohashi; Tsuyoshi Goto; Futoshi Furuya; Akio Obara; Toru Fukushima; Naomi Matsuo; Minji Kim; Masaya Hosokawa; Teruo Kawada; Hiroyuki Hasegawa; Nobuya Inagaki
Journal:  JCI Insight       Date:  2017-05-04

2.  The fate of intravenously administered tetrahydrobiopterin and its implications for heterologous gene therapy of phenylketonuria.

Authors:  Cary O Harding; Mark Neff; Krzysztof Wild; Kelly Jones; Lina Elzaouk; Beat Thöny; Sheldon Milstien
Journal:  Mol Genet Metab       Date:  2004-01       Impact factor: 4.797

3.  Tetrahydrobiopterin in intestinal lumen: its absorption and secretion in the small intestine and the elimination in the large intestine.

Authors:  K Sawabe; Y Saeki; A Ohashi; K Mamada; K O Wakasugi; H Matsuoka; H Hasegawa
Journal:  J Inherit Metab Dis       Date:  2008-11-25       Impact factor: 4.982

4.  Transcellular relocation of tetrahydrobiopterin across Caco-2 cells: a model study of tetrahydrobiopterin absorption through epithelial cells of intestinal mucosa.

Authors:  A Ohashi; M Fukumuro; K Sawabe; K Mamada; Y Sugawara; H Matsuoka; H Hasegawa
Journal:  J Inherit Metab Dis       Date:  2008-11-03       Impact factor: 4.982

Review 5.  Regulation of carbohydrate metabolism by nitric oxide and hydrogen sulfide: Implications in diabetes.

Authors:  Sevda Gheibi; Alan P Samsonov; Shahsanam Gheibi; Alexandra B Vazquez; Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2020-01-21       Impact factor: 5.858

6.  Tetrahydrobiopterin in the prevention of hypertonia in hypoxic fetal brain.

Authors:  Jeannette Vásquez-Vivar; Jennifer Whitsett; Matthew Derrick; Xinhai Ji; Lei Yu; Sidhartha Tan
Journal:  Ann Neurol       Date:  2009-09       Impact factor: 10.422

7.  Tetrahydrobiopterin Supplementation: Elevation of Tissue Biopterin Levels Accompanied by a Relative Increase in Dihydrobiopterin in the Blood and the Role of Probenecid-Sensitive Uptake in Scavenging Dihydrobiopterin in the Liver and Kidney of Rats.

Authors:  Akiko Ohashi; Yusuke Saeki; Tomonori Harada; Masako Naito; Tomihisa Takahashi; Shin Aizawa; Hiroyuki Hasegawa
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

8.  Tetrahydrobiopterin has a glucose-lowering effect by suppressing hepatic gluconeogenesis in an endothelial nitric oxide synthase-dependent manner in diabetic mice.

Authors:  Abulizi Abudukadier; Yoshihito Fujita; Akio Obara; Akiko Ohashi; Toru Fukushima; Yuichi Sato; Masahito Ogura; Yasuhiko Nakamura; Shimpei Fujimoto; Masaya Hosokawa; Hiroyuki Hasegawa; Nobuya Inagaki
Journal:  Diabetes       Date:  2013-05-06       Impact factor: 9.461

9.  Treatment With Tetrahydrobiopterin Improves White Matter Maturation in a Mouse Model for Prenatal Hypoxia in Congenital Heart Disease.

Authors:  Jennifer Romanowicz; Camille Leonetti; Zaenab Dhari; Ludmila Korotcova; Shruti D Ramachandra; Nemanja Saric; Paul D Morton; Shivani Bansal; Amrita Cheema; Vittorio Gallo; Richard A Jonas; Nobuyuki Ishibashi
Journal:  J Am Heart Assoc       Date:  2019-07-23       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.